Virus News and Research

Latest Virus News and Research

COVID-19 immunity in family members reduces risk of infection by 45-97%

An interesting new study examines the risk of COVID-19 to a susceptible individual who is part of a family with COVID-19 immunity.

14 Oct 2021

Increased transmission in open spike conformations of SARS-CoV-2 variants

Researchers from Yale University and the University of Texas have collaborated to investigate mutations in some VOCs.

14 Oct 2021

Assay for the sensitive and specific identification of SARS-CoV-2 Delta variant

Scientists described a quick and inexpensive method for accurately identifying the Delta variant by applying the double-mismatch allele-specific RT-PCR (DMAS-RT-PCR).

14 Oct 2021

Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

A recent study seeks to investigate the characteristics of individuals with breakthrough infections post-vaccination in North Carolina, USA.

14 Oct 2021

Methods used to limit transmission of SARS-CoV-2 effective against other viruses in China

Researchers from Shenzhen's Children's Hospital have been investigating the occurrence of these diseases while these measures were in effect to understand better how to curb their transmission.

14 Oct 2021

COVID-19 booster for immunosuppressed patients with inflammatory bowel disease

Researchers have published correspondence detailing the reasoning behind providing a third booster dose to patients with inflammatory bowel disease that have been treated with drugs that can reduce the response to the COVID-19 vaccines.

14 Oct 2021

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

NewsMed speaks to KNAUER about the company’s background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.

From KNAUER Wissenschaftliche Geräte GmbH 14 Oct 2021

Small portion of COVID-19 patients infectious long-term

In late December 2019, a novel pneumonia-like lung infection was reported in the Chinese province of Hubei. This, in turn, led to the ongoing coronavirus disease-19 (COVID-19) pandemic. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is closely related to SARS (Severe Acute Respiratory Syndrome) and MERS (the Middle East Respiratory Syndrome Coronavirus).

13 Oct 2021

More than half of COVID-19 survivors experience "long COVID", researchers say

More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms - more commonly known as "long COVID" - up to six months after recovering, according to Penn State College of Medicine researchers.

13 Oct 2021

Study reveals the zoonotic potential of the rat Sialodacryoadenitis virus

A new review aimed to describe the current state of knowledge on Sialodacryoadenitis virus, along with its characteristics and potential zoonotic threat.

13 Oct 2021

Anti-rheumatic drug as a potential candidate for treating COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to treat autoimmune and infectious diseases, may also help serve as an antiviral treatment for COVID-19 infection.

13 Oct 2021

New study finds SARS-CoV-2 causes retinal infection

Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.

13 Oct 2021

Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2

A new study aimed to develop a novel CRISPR-Cas12a powered visual biosensor for the detection of SARS-CoV-2.

13 Oct 2021

New high-throughput assay could help development of anti-COVID-19 drugs

In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.

13 Oct 2021

Genetic characteristics of possible new Alphacoronavirus species found in Bats

A recent study identifies a novel Alphacoronavirus isolated from bats, in Korea, in 2020.

13 Oct 2021

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Scientists have characterized T-cell, B-cell, and IgG responses to S antigenic sequences to evaluate vaccine effectiveness.

13 Oct 2021

Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air

How can viruses be effectively eliminated from indoor air? This question is now becoming more important as fall approaches. Efficient indoor air purification is essential, especially in schools.

13 Oct 2021

How long does natural immunity produced by SARS-CoV-2 infection last?

A new study posted to the bioRxiv* preprint server followed the adaptive immune response in convalescent patients from Swedish and Italian cohorts—which had earlier shown long-lasting adaptive immune responses to the G614 strain—for 15 months. Here, specific antibody levels and neutralizing antibody titers were tested against variants of concern (VOCs).

12 Oct 2021

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Researchers in Germany have developed a promising approach to suppressing the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

12 Oct 2021

New eco-friendly solution to fight against malaria

Mosquitoes can and do feed on HMBPP-supplemented beetroot juice. This is the findings of a study at Stockholm University.

12 Oct 2021

Virus News and Research

Latest Virus News and Research

COVID-19 immunity in family members reduces risk of infection by 45-97%

Increased transmission in open spike conformations of SARS-CoV-2 variants

Assay for the sensitive and specific identification of SARS-CoV-2 Delta variant

Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

Methods used to limit transmission of SARS-CoV-2 effective against other viruses in China

COVID-19 booster for immunosuppressed patients with inflammatory bowel disease

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

Small portion of COVID-19 patients infectious long-term

More than half of COVID-19 survivors experience "long COVID", researchers say

Study reveals the zoonotic potential of the rat Sialodacryoadenitis virus

Anti-rheumatic drug as a potential candidate for treating COVID-19

New study finds SARS-CoV-2 causes retinal infection

Role of CRISPR-Cas12a visual biosensor in detection of SARS-CoV-2

New high-throughput assay could help development of anti-COVID-19 drugs

Genetic characteristics of possible new Alphacoronavirus species found in Bats

COVID-19 vaccination induces transient increase in cellular and antibody responses to S1 antigenic sequence

Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air

How long does natural immunity produced by SARS-CoV-2 infection last?

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

New eco-friendly solution to fight against malaria

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in